Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2024-07-26
2024-07-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation and Standardization of Test Methods and Evaluators for Testing of Hair Care Range of Products
NCT05763888
A Clinical Study to Evaluate the Safety, Effectiveness and In-Use Tolerability of Hair Growth and Scalp Health Serum in Subjects With Mild to Moderate Hair Thinning.
NCT07195487
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
NCT06146166
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
NCT07076706
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
NCT03676400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This research seeks to develop and implement a robust and standardized approach that incorporates a diverse range of parameters. These parameters include:
* Measurement of hair regrowth from AGA-affected area.
* Number of new hairs from the AGA-affected area and tattoo area.
* Evaluation of hair strength through tensile testing.
* Assessment of hair length
* Global picture of head crown
* Quantitative analysis of scalp keratin levels.
* Visual documentation and quantitative scoring of baldness using the Norwood-Hamilton and Ludwig scales and its inter-variability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Overall
Other
Assess and Evaluate hair growth and scalp health
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Other
Assess and Evaluate hair growth and scalp health
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Good general health as determined from recent medical history.
3. No previous history of adverse skin conditions, and not under any medication likely to interfere with the results.
4. Patient having androgenic alopecia condition with grade of 1 to 3 (Dermatological assessment)
Exclusion Criteria
2. Pregnant or breastfeeding women will be excluded due to potential hormonal influences on hair growth.
3. History of cancer treatment involving chemotherapy or radiotherapy to the scalp.
4. Presence of significant dermatological conditions affecting the scalp other than androgenetic alopecia (e.g., psoriasis, severe seborrheic dermatitis).
5. History of major systemic diseases (e.g., uncontrolled diabetes, severe cardiovascular diseases, autoimmune disorders).
6. Any other condition which could warrant exclusion from the study, as per the dermatologist/investigator's discretion.
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NovoBliss Research Pvt Ltd
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Maheshvari N Patel
Role: PRINCIPAL_INVESTIGATOR
NovoBliss Research Pvt Ltd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NovoBliss Research Pvt Ltd
Ahmedabad, Gujarat, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NB240033-NB-V
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.